Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
4.485
+0.155 (3.58%)
Nov 21, 2024, 10:54 AM EST - Market open
Codexis Market Cap
Codexis has a market cap or net worth of $364.98 million as of November 21, 2024. Its market cap has increased by 200.39% in one year.
Market Cap
364.98M
Enterprise Value
303.96M
1-Year Change
200.39%
Ranking
Category
Stock Price
$4.49
Market Cap Chart
Since April 22, 2010, Codexis's market cap has decreased from $449.60M to $364.98M, a decrease of -18.82%. That is a compound annual growth rate of -1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 352.40M | 65.45% |
| Dec 29, 2023 | 213.00M | -30.41% |
| Dec 30, 2022 | 306.10M | -84.91% |
| Dec 31, 2021 | 2.03B | 56.76% |
| Dec 31, 2020 | 1.29B | 38.30% |
| Dec 31, 2019 | 935.70M | 3.72% |
| Dec 31, 2018 | 902.10M | 123.46% |
| Dec 29, 2017 | 403.70M | 112.92% |
| Dec 30, 2016 | 189.60M | 11.20% |
| Dec 31, 2015 | 170.50M | 71.01% |
| Dec 31, 2014 | 99.70M | 87.05% |
| Dec 31, 2013 | 53.30M | -35.78% |
| Dec 31, 2012 | 83.00M | -56.43% |
| Dec 30, 2011 | 190.50M | -47.49% |
| Dec 31, 2010 | 362.80M | -19.31% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 355.39M |
| XOMA Royalty | 354.66M |
| Q32 Bio | 354.34M |
| MaxCyte | 350.27M |
| Omeros | 349.44M |
| Contineum Therapeutics | 342.84M |
| Kamada | 342.57M |
| Cross Country Healthcare | 341.35M |